AR221724A1 - Un procedimiento de preparacion de derivados de 1,2-y 1,3-(di-o-n-alquil)-3)o(2)-piperidino glicerol y sus sales de adicion de acidos farmaceuticamente aceptables,utiles como estimulantes no especificos de la inmunidad mediada celularmente - Google Patents

Un procedimiento de preparacion de derivados de 1,2-y 1,3-(di-o-n-alquil)-3)o(2)-piperidino glicerol y sus sales de adicion de acidos farmaceuticamente aceptables,utiles como estimulantes no especificos de la inmunidad mediada celularmente

Info

Publication number
AR221724A1
AR221724A1 AR276517A AR27651779A AR221724A1 AR 221724 A1 AR221724 A1 AR 221724A1 AR 276517 A AR276517 A AR 276517A AR 27651779 A AR27651779 A AR 27651779A AR 221724 A1 AR221724 A1 AR 221724A1
Authority
AR
Argentina
Prior art keywords
alquil
piperidine
immunity
glycerol
derivatives
Prior art date
Application number
AR276517A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR221724A1 publication Critical patent/AR221724A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/44Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reduction and hydrolysis of nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AR276517A 1978-05-15 1979-05-15 Un procedimiento de preparacion de derivados de 1,2-y 1,3-(di-o-n-alquil)-3)o(2)-piperidino glicerol y sus sales de adicion de acidos farmaceuticamente aceptables,utiles como estimulantes no especificos de la inmunidad mediada celularmente AR221724A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/906,260 US4173641A (en) 1978-05-15 1978-05-15 Di-O-n-alkyl glycerol derivatives as immune stimulants

Publications (1)

Publication Number Publication Date
AR221724A1 true AR221724A1 (es) 1981-03-13

Family

ID=25422164

Family Applications (1)

Application Number Title Priority Date Filing Date
AR276517A AR221724A1 (es) 1978-05-15 1979-05-15 Un procedimiento de preparacion de derivados de 1,2-y 1,3-(di-o-n-alquil)-3)o(2)-piperidino glicerol y sus sales de adicion de acidos farmaceuticamente aceptables,utiles como estimulantes no especificos de la inmunidad mediada celularmente

Country Status (38)

Country Link
US (1) US4173641A (da)
JP (2) JPS5924974B2 (da)
AR (1) AR221724A1 (da)
AT (1) AT372678B (da)
AU (1) AU513771B2 (da)
BE (1) BE876229A (da)
CA (1) CA1105935A (da)
CH (1) CH639939A5 (da)
DD (1) DD144540A5 (da)
DE (1) DE2919514C2 (da)
DK (1) DK149946C (da)
EG (1) EG15252A (da)
ES (1) ES480565A1 (da)
FI (1) FI69450C (da)
FR (1) FR2426039A1 (da)
GB (1) GB2021580B (da)
GR (1) GR72419B (da)
GT (1) GT197957869A (da)
HK (1) HK13584A (da)
HU (1) HU180283B (da)
IE (1) IE48229B1 (da)
IL (1) IL57268A (da)
IN (1) IN150574B (da)
IT (1) IT1115217B (da)
KE (1) KE3354A (da)
LU (1) LU81253A1 (da)
MY (1) MY8500096A (da)
NL (1) NL175524C (da)
NO (1) NO151285C (da)
NZ (1) NZ190444A (da)
PH (1) PH15256A (da)
PL (1) PL123910B1 (da)
PT (1) PT69607A (da)
SE (1) SE429966B (da)
SG (1) SG65483G (da)
SU (1) SU1122220A3 (da)
YU (1) YU41156B (da)
ZA (1) ZA792306B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4312877A (en) * 1979-07-09 1982-01-26 Pfizer Inc. 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted piperidines, pharmaceutical compositions, thereof and use thereof
US4255426A (en) * 1979-07-09 1981-03-10 Pfizer Inc. 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted-piperazines and piperidines
US4310550A (en) * 1979-10-26 1982-01-12 Pfizer Inc. Lipid amines formulated with fat or lipid emulsions as vaccine adjuvants
US4395394A (en) * 1979-10-26 1983-07-26 Pfizer Inc. Use of lipid amines formulated with fat or lipid emulsions as vaccine adjuvants
JPS60105650A (ja) * 1983-11-14 1985-06-11 Ono Pharmaceut Co Ltd グリセリン誘導体、その製造方法及びその誘導体を含有する薬剤
US4880626A (en) * 1985-01-18 1989-11-14 Mcmichael John Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome
JPS62156230A (ja) * 1985-12-27 1987-07-11 Nippon Steel Corp 帯状物の蛇行修正方法
US4842862A (en) * 1986-07-03 1989-06-27 International Minerals & Chemical Corp. Immunostimulating agents
ZA899436B (en) * 1988-12-12 1990-08-29 Ciba Geigy Piperidine derivatives
WO2005077963A1 (fr) * 2004-01-16 2005-08-25 Institut Superieur Agricole De Beauvais DErivEs de saccharides et d'itols possEdant un groupement O-alkyle ou un groupement O-alkyle et un groupement O-n-butanoyle. Applications comme mEdicaments dans les pathologies prolifEratives tumorales ou bEnignes.
EP3721943A1 (en) 2009-12-23 2020-10-14 Novartis AG Lipids, lipid compositions and methods of using them

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2738351A (en) * 1952-08-02 1956-03-13 Bristol Lab Inc Substituted glycerol ethers
US3432602A (en) * 1967-12-20 1969-03-11 Astra Ab Oral alkyl glycerol ether improvement in radiation,radiomimetic,or cytostatic tumor therapies
US3943173A (en) * 1972-11-22 1976-03-09 Smithkline Corporation 3-Alkylamino- alpha-aminomethyl-4-hydroxybenzyl alcohols
US4012528A (en) * 1974-06-03 1977-03-15 Smithkline Corporation α-AMINOALKYL-3-(1,2-DIHYDROXYETHYL)-4-HYDROXY-BENZYL ALCOHOLS HAVING β-ADRENERGIC STIMULANT ACTIVITY
US4069223A (en) * 1977-05-02 1978-01-17 G. D. Searle & Co. 4-Aminomethyl-1-(3,3,3-triarylpropyl)-4-arylpiperidine and derivatives thereof
US4166132A (en) * 1977-08-18 1979-08-28 Pfizer Inc. Antiviral amine derivatives of glycerol and propanediols

Also Published As

Publication number Publication date
SG65483G (en) 1984-07-27
MY8500096A (en) 1985-12-31
JPS55378A (en) 1980-01-05
FR2426039A1 (fr) 1979-12-14
IT1115217B (it) 1986-02-03
FI69450B (fi) 1985-10-31
NL7903769A (nl) 1979-11-19
YU109479A (en) 1983-02-28
DE2919514C2 (de) 1982-06-03
DD144540A5 (de) 1980-10-22
DE2919514A1 (de) 1979-11-22
SU1122220A3 (ru) 1984-10-30
IE48229B1 (en) 1984-11-14
IL57268A (en) 1982-05-31
ATA356179A (de) 1983-03-15
JPS58131947A (ja) 1983-08-06
SE7904216L (sv) 1979-11-16
GR72419B (da) 1983-11-03
HK13584A (en) 1984-02-24
AU4701679A (en) 1979-11-22
YU41156B (en) 1986-12-31
GT197957869A (es) 1980-11-04
ES480565A1 (es) 1980-08-16
ZA792306B (en) 1980-05-28
US4173641A (en) 1979-11-06
DK149946C (da) 1987-06-15
EG15252A (en) 1986-09-30
PL215573A1 (da) 1980-07-01
AT372678B (de) 1983-11-10
IE790938L (en) 1979-11-15
DK102479A (da) 1979-11-16
IT7922664A0 (it) 1979-05-14
FI791531A (fi) 1979-11-16
AU513771B2 (en) 1980-12-18
CH639939A5 (fr) 1983-12-15
GB2021580A (en) 1979-12-05
NO151285C (no) 1985-03-13
IL57268A0 (en) 1979-09-30
NZ190444A (en) 1981-05-29
GB2021580B (en) 1982-09-08
DK149946B (da) 1986-11-03
NO151285B (no) 1984-12-03
FR2426039B1 (da) 1983-12-16
NL175524C (nl) 1984-11-16
PT69607A (en) 1979-06-01
JPS5924974B2 (ja) 1984-06-13
CA1105935A (en) 1981-07-28
PL123910B1 (en) 1982-12-31
PH15256A (en) 1982-11-02
JPS6139301B2 (da) 1986-09-03
KE3354A (en) 1983-12-16
SE429966B (sv) 1983-10-10
BE876229A (fr) 1979-11-14
NO791604L (no) 1979-11-16
IN150574B (da) 1982-11-13
FI69450C (fi) 1986-02-10
LU81253A1 (fr) 1979-12-07
HU180283B (en) 1983-02-28

Similar Documents

Publication Publication Date Title
ES489627A0 (es) Procedimiento para la obtencion de derivados de tetrahidro- piridina y piperidina
SE434049B (sv) Forfarande for framstellning av 1,4-dihydropyridinderivat
ES480471A0 (es) Un procedimiento para preparar y utilizar acidos 5-tiazol-carboxilicos 2,4-disubstituidos y sus derivados
IT8048675A0 (it) Acidi 2-(mercapto-1-osso(alchile inferiore)-1,2,3,4-tetraidroisochi nolin-3-carbossilici per impiego farmacologico
ES493440A0 (es) Un procedimiento para la preparacion de nuevos derivados de 4-(3-fenilpropil)piperidina
AR228475A1 (es) Procedimiento para la preparacion de nuevos derivados de n-omega-(4-(3-indolil)-piperidino)-alquil-benzoimidazolonas
AR221724A1 (es) Un procedimiento de preparacion de derivados de 1,2-y 1,3-(di-o-n-alquil)-3)o(2)-piperidino glicerol y sus sales de adicion de acidos farmaceuticamente aceptables,utiles como estimulantes no especificos de la inmunidad mediada celularmente
SE7701460L (sv) Forfarande for framstellning an nya derivat av 1,2-ditiol
AR220567A1 (es) Procedimiento para la preparacion de derivados de 3-((2,4-disustituido)-fenil)-piperidina
SE7701459L (sv) Forfarande for framstellning av nya derivat av 1,2-ditiol
NO790031L (no) Fremgangsmaate for fremstilling av 4-(6`-metoksy-2`-naftyl)butan-2-on
BG26526A3 (bg) Метод за получаване на 1-(бензазолилалкил)пиперидинови производни
ES508025A0 (es) "procedimiento para preparar derivados de dihidropiridina".
IT7925173A0 (it) Procedimento per l'erezione di preriscaldatori d'aria.
IT8050259A0 (it) Derivati di acidi prostanoici 4,5insaturi
IT1163988B (it) Testa alesatrice
PL192578A1 (pl) Sposob wytwarzania nowych n-arylo-n-/1,4-podstawionych piperydynylo/aryloacetamidow
NO771269L (no) Fremgangsm}te ved fremstilling av 2-(2,2-dicyclohexylethyl)-piperidin.
NZ182561A (en) Preparation of 2-(3,4-methylenedioxyphenyl)-ethylamine derivatives
SE7803742L (sv) Nya 1-(3-(3,4,5-trimetoxifenoxi)-2-hydroxi-propyll-4-aryl-piperazin-derivat och forfarande for framstellning derav
NO791725L (no) Fremgangsmaate til innstilling av gjengivelseshode
SE7605518L (sv) Forfarande for framstellning av 3,5-bisoxygenerade 2-(omega-halogen-3-oxygenerad-l-alkenyl)cyklopentan-l-heptansyror och derivat derav
MC1285A1 (fr) Derives d'isoquinoleine
AR215290A1 (es) Procedimiento para la preparacion de 3-(4-(2:-piridil)-piperazin-1-il)-1-(3,4,5-trimetoxi-benzoiloxi)-propano y sus sales farmaceuticamente aceptables
IT1145279B (it) Procedimento per la produzione di 3-(4)-formiltriciclo(5,2,1,0,2,6)-decene-8